Clinical Trial Update: Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a combination of goserelin, flutamide, and radiation therapy for locally advanced prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Goserelin (Goserelin)
• flutamide (flutamide)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED